| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.38▼ | 9.40▼ | 9.49▼ | 9.65▼ | 8.49▲ |
| MA10 | 9.40▼ | 9.56▼ | 9.64▼ | 9.03▲ | 9.21▲ |
| MA20 | 9.43▼ | 9.69▼ | 9.65▼ | 8.17▲ | 7.75▲ |
| MA50 | 9.67▼ | 9.68▼ | 9.53▼ | 9.45▼ | 5.28▲ |
| MA100 | 9.74▼ | 9.46▼ | 8.46▲ | 7.41▲ | 6.26▲ |
| MA200 | 9.69▼ | 8.35▲ | 8.40▲ | 5.58▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.055▼ | -0.072▼ | 0.269▲ | -0.052▼ |
| RSI | 29.065▼ | 37.807▼ | 41.449▼ | 54.904▲ | 57.841▲ |
| STOCH | 18.120▼ | 6.812▼ | 16.653▼ | 75.669 | 29.875 |
| WILL %R | -80.392▼ | -95.050▼ | -95.050▼ | -30.976 | -53.218 |
| CCI | -150.094▼ | -105.733▼ | -156.603▼ | 72.724 | 30.165 |
|
Tuesday, June 23, 2026 01:19 PM
About Artiva Biotherapeutics Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune ...
|
|
Wednesday, June 17, 2026 01:25 PM
Detailed price information for Artiva Biotherapeutics Inc (ARTV-Q) from The Globe and Mail including charting and trades.
|
|
Monday, June 01, 2026 06:57 AM
In a recent move, Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Director, Yong-Jun Huh, participated in the company's initial public ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/06/26 | 9.90 | 10.28 | 9.25 | 9.32 | 476,309 |
| 23/06/26 | 9.25 | 9.9999 | 9.21 | 9.80 | 479,566 |
| 22/06/26 | 9.77 | 10.00 | 9.33 | 9.36 | 464,754 |
| 18/06/26 | 9.93 | 10.4958 | 9.48 | 9.82 | 1,747,772 |
| 17/06/26 | 9.42 | 10.4586 | 9.11 | 9.94 | 952,270 |
| 16/06/26 | 9.14 | 9.23 | 8.5416 | 8.91 | 796,312 |
| 15/06/26 | 8.57 | 9.77 | 8.52 | 9.18 | 782,333 |
| 12/06/26 | 8.61 | 8.83 | 8.10 | 8.54 | 1,432,298 |
| 11/06/26 | 7.42 | 8.005 | 7.27 | 8.00 | 1,067,421 |
| 10/06/26 | 7.80 | 7.8499 | 6.96 | 7.42 | 492,461 |
|
|
||||
|
|
||||
|
|